In many ways, 2018 resembled the previous year in fast motion. Political turmoil accelerated on both sides of the Atlantic, with Asia swept into the fold, while the “estrangement” previously seen between President Donald Trump and the scientific community morphed into global revulsion against a rogue research rule-breaker. Not all was well in biopharma-land, either. […]

by

A science-based traceability system is needed to combat the growing international problem of food fraud in the seafood industry, according to a new report by the FAO. In a recent investigation by Italian authorities, cephalopods like squid were found to be the most mislabeled The United Nations Food and Agricultural Organization (FAO) has published a […]

by

Johnston Asset Management Corp increased its stake in Gw Pharmaceuticals Plc (GWPH) by 48.86% based on its latest 2018Q3 regulatory filing with the SEC. Johnston Asset Management Corp bought 11,320 shares as the company’s stock declined 12.87% with the market. The institutional investor held 34,490 shares of the major pharmaceuticals company at the end of […]

by

It’s been a rough couple of months for GW Pharmaceuticals (NASDAQ:GWPH). The stock sank in February after the biotech reported a major disappointment for its cannabidivarin (CBDV) compound GWP42006 in a phase 2a clinical study targeting treatment of focal seizures.  But the cannabinoid-focused biotech announced important good news last week related to its lead product Epidiolex. You […]

by

UofSC School of Medicine cannabinoid research results in FDA approval of new treatment for autoimmune hepatitis Posted on: July 19, 2018; Updated on: July 19, 2018By Alyssa Yancey, alyssa.yancey@uscmed.sc.edu, 803-216-3302 Prakash Nagarkatti is a Carolina Distinguished Professor and vice president for research. Research from University of South Carolina School of… read more at: https://www.sc.edu/uofsc/posts/2018/07/nagarkattis_research_autoimmune_hepatitis.php

by

article The steady march of new “right-to-work” laws in Republican-led states hit a wall in Missouri, where voters resoundingly rejected a measure that could have weakened union finances after national and local labor groups poured millions of dollars into the campaign against it. Continue Reading Below Missouri’s law against compulsory union fees was defeated Tuesday […]

by

‘+ ‘ ‘+__tnt.truncateStr(oAsset.title.replace(/(]+))/ig,””),iTextTrun,’…’)+’ ‘+ ‘ ‘+__tnt.truncateStr(oAsset.summary.replace(/(]+))/ig,””),iTextTrun,’…’)+’ ‘+ ‘ … read more at: http://www.gwinnettdailypost.com/local/clark-blasts-cagle-unterman-on-house-floor-over-medical-marijuana/article_734f4067-da4a-5444-97fa-57a34bfd001a.html

by

Sativex, a mixture of two active compounds of cannabis, may help control symptoms of spasticity (stiff muscles) in people with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis, a Phase 2 trial shows. The study “Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase […]

by

By Donna Gregory Burch Chronic illness can be a huge financial drain. As someone who is living with fibromyalgia and chronic Lyme, most of the money I make from working part time is spent on my treatment. I hand over hundreds of dollars every month for the cleanest, healthiest food I can find. I spend way […]

by